Author: CBD-Intel
Pennsylvania medical cannabis vape recall leaves patients stranded
Written by CBD-Intel || 13th May 2022 || Regulatory briefing |
A widespread recall of cannabis concentrates sold for vaping at medical cannabis dispensaries in the US state of Pennsylvania has left patients with more questions than answers about who to trust ...
Argentina approves law to establish legal framework for cannabis and hemp
Written by CBD-Intel || 13th May 2022 || Regulatory briefing |
Members of the Argentina Chamber of Deputies approved a law on 5th May that would establish a legal framework for the production, sale and export of medical cannabis as well as industrial hemp, a decision president Alberto Fernández...
Basel moves forward with its recreational cannabis trial
Written by CBD-Intel || 6th May 2022 || Regulatory briefing |
Basel will start allowing the sale of recreational cannabis through local pharmacies at the end of the summer as the first Swiss city to win the approval of health authorities for the pilot project ...
Kanabo acquires The GP Service in a bid to ‘bring cannabis to the UK mainstream’
Written by CBD-Intel || 3rd May 2022 || Business briefing |
Medicinal cannabis company Kanabo has bought private telemedicine platform The GP Service in a £14m deal to make its products – and those of rival companies – more accessible in the UK ...
Optimism blooming as Uruguay’s first medical cannabis harvest begins
Written by CBD-Intel || 25th April 2022 || Business briefing |
Yvy Life Sciences, the first company authorised to grow medical-grade cannabis plants in Uruguay, has started harvesting its first crops for this purpose ...
E-commerce platform Shopify accused of shutting down legal delta-8 THC sales
Written by CBD-Intel || 19th April 2022 || Business briefing |
US-based CBD shops that used Shopify to support online sales are still dealing with the fallout weeks after the e-commerce platform suddenly removed sites it deemed non-compliant ...
Appeals court hands hemp company a victory in Polish ‘novel food’ battle
Written by CBD-Intel || 14th April 2022 || Regulatory briefing |
A Polish appeals court has accepted arguments that hemp was consumed before 1997, making it non-novel and leading the court to overturn a decision by the country’s Chief Sanitary Inspectorate ...
Argentine bill to establish legal cannabis industry set to be passed ‘within weeks’
Written by CBD-Intel || 14th April 2022 || Regulatory briefing |
Argentina’s Chamber of Deputies is expected to approve a bill creating a legal framework for the cultivation, manufacture and sale of medicinal cannabis and hemp “within two months”, CBD-Intel has been told ...
EIHA gives warm welcome to EU-wide THC limits, but uncertainties remain
Written by CBD-Intel || 13th April 2022 || Regulatory briefing |
Maximum THC levels for hempseed foods and oil across the EU are a major step forward in clarifying the regulation of hemp-derived products, according to the European Industrial Hemp Association (EIHA) ...
Canada’s cannabis industry welcomes a federal budget full of good things
Written by CBD-Intel || 11th April 2022 || Regulatory briefing |
Canada’s cannabis trade is celebrating after the government tabled a budget calling for steps to streamline a variety of tax measures and launch a strategy group to examine ways to grow the industry ...
So far so good, but German lawmakers urged to go further on medical cannabis
Written by CBD-Intel || 11th April 2022 || Regulatory briefing |
Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply – but there are still some unanswered issues on policy and practice that lobbyists want addressed ...
Morocco authorises cannabis growth for medical purposes in three regions
Written by CBD-Intel || 8th April 2022 || Regulatory briefing |
The Cabinet of the Moroccan government has formally adopted the decision to authorise three regionsto lawfully grow cannabis solely for medical purposes ...
Argentina’s president and development minister back cannabis framework
Written by CBD-Intel || 7th April 2022 || Regulatory briefing |
Argentina’s president is urging the national Congress to approve a law this year that would establish a legal framework for the production and sale of medicinal cannabis and industrial hemp ...
Long trips for a short supply, but there’s optimism in Iowa on medical cannabis
Written by CBD-Intel || 6th April 2022 || Regulatory briefing |
Patients in Iowa who rely on supplies of medical cannabis are tightly restricted in how much they can have, and may face a long trip to get it from one of the few licensed dispensaries in the US...
People vs politics – Wisconsin remains divided over what to do about cannabis
Written by CBD-Intel || 4th April 2022 || Regulatory briefing |
Lawmakers in the US state of Wisconsin are sympathetic to patients who could benefit from medical cannabis – but they don’t want to go against federal law ...
Through a glass darkly – CHUMP aims to spread a little post-Brexit light on CBD
Written by CBD-Intel || 1st April 2022 || Regulatory briefing |
UK authorities moved today (1st April) to give new clarity on the legal status of CBD and other cannabinoids, with a new department ready to clear up Home Office mess ...
Canada’s proposed changes could open up non-therapeutic cannabis research
Written by CBD-Intel || 31st March 2022 || Regulatory briefing |
The Canadian government is proposing changes to make it easier to conduct non-therapeutic cannabis research in the country and to foster more investigation into the development of cannabis products ...
Disappointment across US after CBD language dropped from omnibus bill
Written by CBD-Intel || 29th March 2022 || Regulatory briefing |
CBD stakeholders hoping for clarity in US regulations were left disappointed by the passing of the $1.5tn omnibus spending bill earlier this month as some helpful language was dropped during the final negotiations ...
European Commission moving ahead slowly on permissible THC levels in food
Written by CBD-Intel || 24th March 2022 || Regulatory briefing |
THC levels have been established for certain hemp foodstuffs, which may later govern the amount of THC allowed in ingestible cannabinoid products, experts working for the European Commission have confirmed ...
Canada ready to raise the legal limit on purchases of cannabis-infused drinks
Written by CBD-Intel || 22nd March 2022 || Regulatory briefing |
The Canadian government is proposing a change in the regulations governing cannabis-infused beverages to increase the number of drinks that can legally be bought at a time ...
Poland set to grow cannabis for medical use after Senate ratifies hemp bill
Written by CBD-Intel || 15th March 2022 || Regulatory briefing |
The Polish Senate has passed a bill introducing new regulations on hemp growing and medical cannabis with minimal changes from the version already approved by the lower parliamentary chamber, the Sejm ...
South Dakota in the US passes legislation making delta-8 THC legal for adult use
Written by CBD-Intel || 14th March 2022 || Regulatory briefing |
South Dakota’s Republican governor, Kristi Noem, has signed House Bill (HB) 1292, legalising the sale of delta-8 THC, THC-O acetate, and hexahydrocannabinol (HHC) in the state after the bill flew through the state legislature almost unanimously ...
Costa Rica legalises medicinal cannabis as well as commercial hemp production
Written by CBD-Intel || 8th March 2022 || Regulatory briefing |
Costa Rican president Carlos Alvarado ratified a bill on 2nd March that legalises the sale and distribution of medicinal cannabis and allows for the commercial production of hemp in the Central American nation ...
Could the Pfizer acquisition of Arena be a sign of things to come in Big Pharma?
Written by CBD-Intel || 4th March 2022 || Business briefing |
While Big Pharma acquisitions of companies involved in the development of cannabinoid treatments are expected to to propel and expand cannabinoid treatment options, the overall impact of and interest in Big Pharma’s reach into the industry remains a...
New York’s new law could offer some liberty for local hemp producers
Written by CBD-Intel || 4th March 2022 || Business briefing |
Hemp companies are poised to benefit from a new law in New York put forward to help ease supply issues that often occur when a state opens up a legal recreational cannabis market ...
Medical and recreational cannabis – a global overview
Written by CBD-Intel || 4th March 2022 || Regulatory reports , Regulatory trackers |
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...
‘A major step forward’ for CBD as EC validates a few novel food applications
Written by CBD-Intel || 2nd March 2022 || Business briefing |
The European Food Safety Authority (EFSA) has validated the novel food applications of at least five CBD producers, marking what one company called an “important milestone” in the ongoing saga of EU CBD regulation ...
Italian Constitutional Court rejects referendum on decriminalising cannabis
Written by CBD-Intel || 25th February 2022 || Regulatory briefing |
An Italian referendum on the potential decriminalisation of cannabis for personal use has been rejected by the country’s Constitutional Court ...
Mississippi medical cannabis bill finally becomes law
Written by CBD-Intel || 25th February 2022 || Regulatory briefing |
Mississippi has finally signed a medical cannabis bill into law after a long and often arduous...
SAFE amendment to America COMPETES Act unlikely to be part of final bill proposal
Written by CBD-Intel || 22nd February 2022 || Regulatory briefing |
The SAFE Banking Act, which sets out to protect banks from being penalised for providing services to legitimate cannabis-related businesses, is on shaky ground ...
CBD-Intel regulatory news in brief, 12th-18th February
Written by CBD-Intel || 21st February 2022 || Alerts Array , Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Greece, Italy, Switzerland, the UK, US federal, Alabama, Alaska, Arizona, Florida, Indiana, Mississippi, Ohio, South Dakota, Tennessee, Argentina, Chile, India, Thailand and Uruguay ...
Thailand relaxes the rules on cannabis, removing whole plant from narcotics list
Written by CBD-Intel || 21st February 2022 || Regulatory briefing |
Thailand has removed the entire cannabis plant including flowers and seeds from the country’s list of Category 5 narcotics ...
The changing face of endorsements as they get more mainstream – and whiter
Written by CBD-Intel || 17th February 2022 || Blog , Business briefing |
What was once the purview of more “controversial” or “alternative” names has now become the territory of mainstream celebrities designed to appeal to a wider – and whiter – audience ...CBD-Intel regulatory news in brief, 5th-11th February
Written by CBD-Intel || 14th February 2022 || Alerts Array , Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Greece, Italy, Switzerland, the UK, US federal, Alabama, Alaska, Arizona, Florida, Indiana, Mississippi, Ohio, South Dakota, Tennessee, Argentina, Chile, India, Thailand and Uruguay ...
South American legislation on cannabis and hemp will progress, if slowly, in 2022
Written by CBD-Intel || 8th February 2022 || Regulatory briefing |
This is an important year for positive legislation affecting cannabinoids across South America, though some depends on election results and all of it will take a few years to take effect ...
Costa Rica’s president promises to get cannabis legalisation done despite veto
Written by CBD-Intel || 7th February 2022 || Regulatory briefing |
Costa Rican president Carlos Alvarado, who has supported the legalisation of cannabis throughout his administration, has partially vetoed a bill that would have legalised medicinal cannabis and industrial hemp ...CBD-Intel regulatory news in brief, 29th January-4th February
Written by CBD-Intel || 5th February 2022 || Alerts Array , Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Greece, Italy, Switzerland, the UK, US federal, Alabama, Alaska, Arizona, Florida, Indiana, Mississippi, Ohio, South Dakota, Tennessee, Argentina, Chile, India, Thailand and Uruguay ...
Early research shows some cannabinoids can prevent Covid-19 infecting cells
Written by CBD-Intel || 3rd February 2022 || Business briefing |
Research from scientists at the University of Oregon suggests that certain cannabinoids can stop the SARS-CoV-2 (Covid-19) virus from infecting cells. This may lead to future treatments ...
Intoxicating but legal? Expert views differ as US firms take the risk on delta-9 THC
Written by CBD-Intel || 1st February 2022 || Business briefing |
Hemp companies are creating new products marketed to get the user high legally in all 50 US states. Industry experts disagree on whether these companies are risk-taking pioneers, or simply shortsighted ...CBD-Intel regulatory news in brief, 22nd-28th January
Written by CBD-Intel || 29th January 2022 || Alerts Array , Regulatory alerts roundup |
This week's regulatory news in brief includes updates from Belgium, Czech Republic, France, Iceland, UK, Canada, US, Argentina, Costa Rica, Hong Kong, Indonesia and Thailand ...
Ambiguity and misinformation on Italian hemp decree spread yet more confusion
Written by CBD-Intel || 28th January 2022 || Regulatory briefing |
A recent agreement to update the Italian list of officinal (medically usable) plants has caused some unfounded consternation in the country’s CBD industry ...
French government defeated in court as hemp flower sales ban is suspended
Written by CBD-Intel || 27th January 2022 || Regulatory briefing |
France’s highest administrative court has temporarily and partially suspended the French decree banning the sale and consumption of CBD hemp flowers ...
US lawsuits end DEA restrictions on sources of cannabis for researchers
Written by CBD-Intel || 26th January 2022 || Regulatory briefing |
Lawsuits in the US have finally overturned the DEA's requirement that researchers interested in studying cannabis could only purchase from one source, the University of Mississippi ...
German pharma firm buys €80m C3 to boost its European cannabis presence
Written by CBD-Intel || 26th January 2022 || Business briefing |
German pharmaceutical manufacturer Dermapharm Holding is paying Canadian cannabis giant Canopy Growth €80m for the Cannabinoid Compound Company (C3) ...
Native Americans can help Audacious bid for jump start on NY recreational licence
Written by CBD-Intel || 24th January 2022 || Business briefing |
Audacious Brands is the latest cannabis company to look at a partnership with a Native American tribe to gain a head start in the New York recreational cannabis market ...CBD-Intel regulatory news in brief, 15th-21st January
Written by CBD-Intel || 21st January 2022 || Alerts Array , Regulatory alerts roundup |
This week's regulatory news in brief includes updates from France, Germany, Lithuania, Malta, Canada, Mexico, the US, the Bahamas, Brazil, Malaysia and Thailand ...
Italian hemp farm aid and research grants fail to win over the industry
Written by CBD-Intel || 21st January 2022 || Business briefing |
€3m in aid has been allocated to the hemp supply chain following a decree by minister of agriculture Stefano Patuanelli issued in late December 2021 ...
Polish Sejm drafts laws to govern hemp farming for medical applications
Written by CBD-Intel || 20th January 2022 || Regulatory briefing |
A bill governing growing and harvesting of hemp for pharmaceuticals has been passed to the Sejm’s Health Commission and the Agriculture and Rural Development Commission ...